Previous studies have found that PDK1 is overexpressed in multiple myeloma (MM) (39), acute myeloid leukemia (AML) (40), breast invasive carcinoma (BRCA) (41), and OS (42). Here, PDK1 is linked to acute myeloid leukemia.